Tolerability of a Modified Health-Dx

Celero Systems, Inc.10 enrolled

Overview

Single Blind, Randomized Control Study is designed to evaluate the tolerability of the Celero Systems' modified Health-Dx™ (mHDx) capsule.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

OTHER

Masking

DOUBLE

Enrollment

Conditions

Healthy Volunteers

Interventions

modified Health- Dx™ (mHDx) study capsuleDEVICE

The Study mHDx capsule has a mechanism that allows the mHDx to remain resident in the stomach for no more than six (6) hours. After this residency period, the Study mHDx will disassemble and pass safely through the subject's gastrointestinal system.

modified Health- Dx™ (mHDx) control capsuleDEVICE

The Control mHDX capsule does not have a functional residency mechanism so it will disassemble once safely through the esophagus (within 10 minutes) and will then pass safely through the subject's gastrointestinal system.

Eligibility

Sex: ALLMin age: 18 YearsMax age: 75 YearsHealthy volunteers:

Medical Language ↔ Plain English

Inclusion Criteria: * Healthy individuals ages 18 - 75 inclusive * Subject is a suitable candidate for study participation in the opinion of the Investigator * Subject has been informed of the nature of the study and has provided written informed consent as approved by the WVU IRB Exclusion Criteria: * Subjects with a history of any condition that may impact the GI tract * Subjects who are unable to swallow a 000 sized capsule * Subjects with an implanted medical device that has wireless data communication capability * Subjects planning to undergo an MRI within 30 days after the study * Subjects with a BMI \> 40 (severe obesity) * Subjects who are pregnant or are nursing * Any subject deemed to be at risk of a gastrointestinal complication as evaluated by a gastroenterologist prior to study enrollment

Locations (1)

West Virginia University

Morgantown, West Virginia, United States

Outcomes

Primary Outcomes

The difference, if any, in tolerability between the Study and Control as reported via the study questionnaire. mHDx as reported by the subjects.

Time frame: day 1

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.